For citations:
Kuligina E.V., Rzhevsky D.I., Murashev A.N., Kochneva G.V., Koval O.A., Richter V.A. Safety of an antitumor drug based on the recombinant vaccinia virus strain VV-GMCSF-Lact (preclinical studies). Drug development & registration. 2026;15(3):256-270. (In Russ.) https://doi.org/10.33380/2305-2066-2026-15-3-2369
JATS XML


































